Ezetimibe

ezetimibe
(ee zet' ah mib)

Zetia
Pregnancy Category C
Drug classes
Cholesterol-lowering agent
Cholesterol absorption inhibitor
Therapeutic actions
Localizes in the brush border of the small intestine and inhibits the absorption of
cholesterol from the small intestine; this leads to a decrease delivery of dietary
cholesterol to the liver, which will then increase the clearance of cholesterol from the
blood and lead to a decrease in serum cholesterol.
Indications
• As an adjunct to diet and exercise to lower the cholesterol, LDL and Apo-B levels
in patients with primary hypercholesterolemia as monotherapy or in combination
with HMG-CoA reductase inhibitors (statins) or bile acid sequestrants
• In combination with atorvastatin or simvastatin for the treatment of homozygous
familial hypercholesterolemia as adjuncts to other lipid-lowering treatments
• As adjunctive therapy to diet for the treatment of homozygous sitosterolemia to
reduce elevated sitosterol and campesterol levels
Contraindications and cautions

• Contraindicated with allergy to any component of the drug. If given in
combination with an HMG-CoA reductase inhibitor, contraindicated with
pregnancy, lactation, active liver disease, or unexplained persistent increases in
serum transaminase levels.
• In monotherapy, use cautiously with liver dysfunction, pregnancy, lactation,
elderly patients.
Pharmacokinetics
Route Onset Peak
Oral Moderate 4–12 hr
Metabolism: Small intestine and hepatic; T1/2: 22 hr

Distribution: May cross placenta; may enter into breast milk
Excretion: Feces and urine
Available forms
Tablets—10 mg
Dosages
ADULTS
10 mg/day PO taken without regard to food; may be taken at the same time as an HMG-
CoA reductase inhibitor; if combined with a bile acid sequestrant, should be taken > 2 hr
before or > 4 hr after the bile acid sequestrant.
PEDIATRIC PATIENTS
Safety and efficacy not established.
Adverse effects
• CNS: Headache, dizziness, fatigue
• GI: Abdominal pain, diarrhea
• Respiratory: Pharyngitis, sinusitis, upper respiratory infection, cough
• Other: Back pain, myalgia, arthralgia, viral infection
Interactions
Drug-drug
• Decreased serum levels and decreased effectiveness of ezetimibe if combined
with cholestryamine; monitor patient closely and space ezetimibe dosing > 2 hr
before or > 4 hr after the other drug
• Increased serum levels of ezetimide if combined with fenofibrate, gemfibrozil
• Risk of cholethiasis if combined with fibrates (concomitant use with fibrates not
recommended)
• Risk of increased levels and toxicity of exetimibe if combined with cyclosporine;
if this combination is used; monitor patient very carefully
Nursing considerations
Assessment
• History: Allergy to any component of the drug; pregnancy, liver dysfunction,
lactation, evidence of diet and exercise program
• Physical: Skin lesions, color, temperature; orientation, affect; liver evaluation,
bowel sounds; lipid studies, liver function tests
Interventions
• Monitor serum cholesterol, LDLs, triglycerides before starting treatment and
periodically during treatment.
• Determine that patient has been on low cholesterol diet and exercise program for
at least 2 wk before starting ezetimibe.
• If used as part of combination therapy; give drug at the same time as HMG-CoA
reductase inhibitors and > 2 hr before or > 4 hr after bile acid sequestrants.
• Encourage the use of barrier contraceptives if used with an HMG-CoA reductase
inhibitor.
• Help mother to find another method of feeding her baby if this drug is needed for
a nursing woman, it is not known if the drug enters breast milk.
• Consult with dietician regarding low cholesterol diets and provide information
about exercise programs.
• Arrange for regular follow-up during long-term therapy.
Teaching points
• Take drug once each day at a time that is easy for you to remember. Do not take
more than one tablet per day.
• Continue to take any other lipid-lowering drugs that have been prescribed for
you. If you are also taking a bile acid sequestrant, take this drug at least 2 hr
before or at least 4 hr after the bile sequestrant.
• Continue to follow your low-fat diet and participate in an exercise program.
• Plan to return for periodic blood tests, including tests of liver function and
cholesterol levels, to evaluate the effectiveness of this drug.
• These side effects may occur: Abdominal pain, diarrhea (these usually pass with
time, notify your health care provider if this becomes a problem); dizziness,
(avoid driving and operating dangerous machinery until you know how this drug
affects you); headache (analgesics may help).
• Report unusual muscle pain, weakness, or tenderness; severe diarrhea; respiratory
infections.
Adverse effects in Italic are most common; those in Bold are life-threatening.

Ezetimibe

Uploaded by

Copyright:

Available Formats

Ezetimibe

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Ezetimibe

Uploaded by

Copyright:

Available Formats

ezetimibe

(ee zet' ah mib)

Contraindications and cautions

Metabolism: Small intestine and hepatic; T1/2: 22 hr

You might also like